|
Price: $218.4400
$-6.15 
-2.738%
|
| Day's High:
| $222.97000122070312
| Week Perf:
| -4.88 %
|
| Day's Low: |
$ 217.32 |
30 Day Perf: |
-8.01 % |
| Volume (M): |
670,554 |
52 Wk High: |
$ 269.44 |
| Volume (M$): |
$ 0 |
52 Wk Avg: |
$235.47 |
| Open: |
$221.93 |
52 Wk Low: |
$195.14 |
|
|
| Market Capitalization (Millions $) |
21,560 |
| Shares
Outstanding (Millions) |
99 |
| Employees |
18,179 |
| Revenues (TTM) (Millions $) |
5,936 |
| Net Income (TTM) (Millions $) |
785 |
| Cash Flow (TTM) (Millions $) |
268 |
| Capital Exp. (TTM) (Millions $) |
369 |
Business Description
Steris Plc is a prominent global leader in the provision of sterilization and infection prevention solutions across various industries, including healthcare, life sciences, industrial manufacturing, and pharmaceuticals. Founded in 1985 and headquartered in Dublin, Ireland, the company has established itself as a crucial player in ensuring safety and efficacy in environments that require stringent infection control measures.
Product Offerings
Steris Plc offers an extensive range of products designed to meet the diverse needs of its customers:
- Sterilizers: These are essential for the sterilization of surgical instruments, medical devices, and laboratory equipment, ensuring that they are free from all microorganisms.
- Washer-Disinfectors: Designed to clean and disinfect medical equipment and instruments, these devices are critical in healthcare settings to maintain hygiene standards.
- Endoscope Cleaning and Disinfection Systems: These systems play a vital role in ensuring that endoscopes are effectively cleaned and sterilized between uses to avert cross-contamination.
- Biological Indicators: Used to monitor the effectiveness of sterilization processes, these indicators help in validating that the sterilization parameters have been met.
Services
Beyond product offerings, Steris Plc provides a range of services that support its customers:
- Equipment Maintenance: This includes routine maintenance and repairs to ensure that sterilization equipment operates efficiently and effectively.
- Technical Support: Steris Plc offers expert technical assistance to address any operational challenges that customers may face with their sterilization systems.
- Training Services: To ensure optimal performance and compliance, the company provides training for healthcare and laboratory personnel on the proper use of its products and systems.
Market Segments
The largest market for Steris Plc is the healthcare sector, where the company supplies products and services to healthcare providers. These solutions are designed to protect patients from healthcare-associated infections (HAIs). Steris Plcs offerings help maintain sterile environments in operating rooms, patient care areas, and other clinical settings.
In addition to healthcare, Steris Plcs life sciences segment caters to biopharmaceutical manufacturing companies, providing sterilization and infection prevention solutions critical for preventing contamination and ensuring the quality of biopharmaceutical products.
The company’s industrial segment addresses the needs of manufacturing processes that require sterilization and contamination control, particularly in settings such as research laboratories and biotechnology industries.
Commitment to Sustainability and Corporate Responsibility
Steris Plc is dedicated to sustainability and corporate responsibility. The company actively seeks to minimize its environmental footprint through various initiatives in its operations, products, and supply chain practices. This commitment extends to promoting diversity and inclusion within its workforce, aiming to create a supportive and dynamic working environment.
Overall Impact
Through its comprehensive range of infection prevention and sterilization solutions, Steris Plc plays a vital role in improving patient safety, ensuring product integrity, and creating cleaner environments across multiple industries. The company’s focus on innovation and customer satisfaction has solidified its position as a trusted leader in the sterilization and infection prevention market.
Company Address: 70 Sir John Rogerson s Quay, Dublin 2, 0
Company Phone Number: 232 2000 Stock Exchange / Ticker: NYSE STE
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Dividend
Published Tue, Jan 28 2025 10:00 PM UTC
STERIS Strengthens Shareholder Confidence with New Dividend Declaration Amid Growth AspirationsIn a notable commitment to enhancing shareholder value, STERIS plc (NYSE: STE) declared an interim quarterly dividend of $0.57 per share on January 28, 2025. The dividend will be paid out on March 21, 2025, to all shareholders on record as of the close of business on February 20, ...
|
| Dividend
Published Wed, Oct 30 2024 8:30 PM UTC
STERIS plc Announces Quarterly Dividend, Reaffirming Shareholder Commitment Amid Strategic Growth Overview of Dividend AnnouncementDUBLIN, IRELAND, Oct. 30, 2024 STERIS plc (NYSE: STE), a global leader in infection prevention, announced today a quarterly interim dividend of $0.57 per share. This commitment continues the Company s tradition of returning capital to sharehold...
|
| Dividend
Published Wed, Jul 31 2024 8:30 PM UTC
STERIS Increases Dividend Amidst Growing Earnings: Promises Steady Returns for Shareholders
In a recent announcement that signifies stability and growth, STERIS plc (NYSE: STE) declared a quarterly interim dividend of $0.57 per share, marking a $0.05 increase from the previous payout. This decision, unveiled in a press release dated July 31, 2024, highlights the company ...
|
| Merger and Acquisition
Published Thu, Apr 11 2024 10:58 AM UTC
DUBLIN, IRELAND, April 11, 2024 - STERIS plc (NYSE: STE) has recently announced its plan to sell its Dental segment to Peak Rock Capital, a reputable mid-market private investment firm, for a total consideration of $787.5 million. This divestiture aligns with STERIS strategy to strengthen its focus on providing infection prevention, decontamination, surgical, and ...
|
| Dividend
Published Tue, Oct 31 2023 10:05 PM UTC
DUBLIN, IRELAND, Oct. 31, 2023 - Steris Plc (NYSE: STE) has recently declared that it will be distributing a quarterly interim dividend of $0.52 per share. This proactive move by Steris aims to provide stability and reassurance to shareholders during a time of market volatility. The dividend payment is scheduled for December 21, 2023, and will be distributed to sharehol...
|
Fundamental Analysis
| Per Share |
Current |
| Earnings (TTM) |
7.92 $ |
| Revenues (TTM) |
60.14 $
|
| Cash Flow (TTM) |
2.71 $ |
| Cash |
-
|
| Book Value |
72.92 $
|
| Dividend (TTM) |
2.45 $ |
| Efficiency
|
Current |
| Revenue per Employee
(TTM) |
326,525 |
| Net
Income per Employee (TTM) |
43,187 |
| Receivable Turnover Ratio (TTM) |
5.89 |
| Inventory Turnover Ratio (TTM) |
5.27 |
| Asset Turnover Ratio (TTM) |
0.58 |
|
|
| Per Share |
|
| Earnings (TTM) |
7.92 $
|
| Revenues (TTM) |
60.14 $ |
| Cash Flow (TTM) |
2.71 $ |
| Cash |
-
|
| Book Value |
72.92 $ |
| Dividend (TTM) |
2.45 $ |
|
|
| |
| Healthcare |
|
 71.1 % |
of total Revenue |
| Applied Sterilization Technologies |
|
19.16 % |
of total Revenue |
| Life Sciences |
|
9.74 % |
of total Revenue |
| IRELAND |
|
1.78 % |
of total Revenue |
| UNITED STATES |
|
72.66 % |
of total Revenue |
| Other locations |
|
25.55 % |
of total Revenue |
| Capital equipment Healthcare |
|
18.19 % |
of total Revenue |
| Capital equipment Applied Sterilization Technologies |
|
0.68 % |
of total Revenue |
| Capital equipment Life Sciences |
|
2.23 % |
of total Revenue |
| Consumables Healthcare |
|
25.87 % |
of total Revenue |
| Consumables Life Sciences |
|
5.07 % |
of total Revenue |
| Service Healthcare |
|
27.05 % |
of total Revenue |
| Service Applied Sterilization Technologies |
|
18.47 % |
of total Revenue |
| Service Life Sciences |
|
2.44 % |
of total Revenue |
|
|
4.88%